ArticleJournal of hepatocellular carcinoma2025

Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Sintilimab Plus Bevacizumab Biosimilar in the Treatment of Unresectable Hepatocellular Carcinoma.

Huixia Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.